EUR/USD & Gold Outlook Remained Unchanged

By: Miguel A. Rodriguez

13:10, 10 November 2020

1604997253.jpg
Stocks and treasury yield rally on a strong risk-on sentiment.

The FED Warns 

 

The Federal reserves expressed concerns about rising numbers of the coronavirus in the US may put some states on track to impose a new lockdown similar to the one in Europe.

 

This will lead the US economy to contract to -2.0% and the contract percentage could be more depending on the severity of the lockdown measures. Additionally, it will affect companies’ ability to pay their debts and their employee’s wages.

 

Japan’s New Package

 

Japan PM Mr. Suga asked his government to work on a new stimulus package to help the economy to recover from the COVID-19 negative effects on the macro and microeconomic levels and to attract private investments however, it is not clear yet the size of this package. Meanwhile, the Japanese Yen and other safe-haven assets were under pressure on Monday due to risk-on sentiment in the market.

 

It is noteworthy that, the Japanese economy benefitted previously from two stimulus packages, including business loans and helicopter money to households.

 

 

COVID-19 Vaccine 90% Effective!!

 

On Monday, risk-related assets rallied sharply on Pfizer’s announcement of its coronavirus vaccine. The company stated that the vaccine was “more than 90% effective” in preventing infection according to findings from a large-scale trial.

 

Stocks mainly affected by the coronavirus like airlines benefited from yesterday’s news and led the S&P500 with the Dow Jones to all-time highs while the NASDAQ (technology stocks) retreated as a gradual return to normal life would affect these companies’ profits.

 

Although the news of an over 90% might sound promising, however, there is still a lot of time to wait until the vaccine gets the regulatory health approval and produced and distributed on large scale. 

 

Stock Market

Change %

S&P 500

+1.2%

Dow Jones

+2.9%

NASDQ

-0.8%

Japan 225

+3.7%

DAX 30

+4.1%

FTSE 100

+4.3%

CAC 40

+6.7%

EUR/USD and Main FX Markets 

The US Dollar declined at the start of Monday’s session however, it recovered some territory as the vaccine’s updates increased expectations of future growth of the US economy. The US Dollar index technical outlook remains neutral while above 91.72.

The EUR/USD tested on Monday its highest level in ten weeks however, the pair failed to close above 1.1909. A close above this level could change the market’s outlook from neutral to positive.

The GBP/USD tested a multi-week high at 1.3197 then retreated and closed in the current trading zone  1.2916- 1.3184 highlighting bulls indecision. While Jonson’s internal market bill was defeated in the house of Lords the UK PM admitted that the UK-US trade deal won’t be a “Pushover” under Biden. 

 

Gold and Oil

The crude price edged higher on Monday due to the coronavirus vaccine’s updates that could increase expectations of global demand in 2021. Additionally, the OPEC + hints at an extension of production’s cut in 2021. The Brent Crude rallied by 6% to $43.45. The price could trade towards $43.58 and a close above that level could lead the price towards $44.50 a barrel.

The Gold price slipped to a six-week low at $1,850 due to the inverse correlation between Gold and treasury yield. On Monday, the 10 years treasury yield rallied by 14% and neared 1.0%. The outlook of the precious metal remains neutral while above $1,860, a close below this level could change it to negative.

 

Looking Ahead

Markets expect French and Italian industrial production figures of September at 10:00 AM (GMT), then the Eurozone Zew index of November at 11:00 AM and the Fed Quarles’s testimony at 8:00 PM.

Share this article

This information prepared by capex.com/za is not an offer or a solicitation for the purpose of purchase or sale of any financial products referred to herein or to enter into any legal relations, nor an advice or a recommendation with respect to such financial products.This information is prepared for general circulation. It does not regard to the specific investment objectives, financial situation, or the particular needs of any recipient.You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation, or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.This information may not be published, circulated, reproduced, or distributed in whole or in part to any other person without the Company’s prior written consent.
Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of capex.com/zaJME Financial Services (Pty) Ltd trading as CAPEX.COM/ZA acts as intermediary between the investor and Magnasale Trading Ltd, the counterparty to the contract for difference purchased by the Investor via CAPEX.COM/ZA, authorised & regulated by the Cyprus Securities and Exchange Commission with license number 264/15.  Magnasale Trading Ltd is the principal to the CFD purchased by investors.